Whole-body tremulousness: Isolated generalized polymyoclonus

Archives of Neurology

Volumn 64, Issue 9, 2007, Pages 1318-1322

  McKeon, Andrew ^a   Pittock, Sean J ^a   Glass, Graham A ^a   Josephs, Keith A ^a   Bower, James H ^a   Lennon, Vanda A ^a,b   Ahlskog, J Eric ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; CLONAZEPAM; ETIRACETAM; FLUOXETINE; GABAPENTIN; METHYLPREDNISOLONE SODIUM SUCCINATE; NARCOTIC AGENT; OPIATE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ARTICLE; AUTOIMMUNITY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EXAMINATION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; GAIT DISORDER; HUMAN; INVOLUNTARY MOVEMENT; MALE; METASTASIS; MYOCLONUS; PRIORITY JOURNAL; REPEATED DRUG DOSE; SEROLOGY; SYMPTOM; TREATMENT OUTCOME; TREMOR;

ADULT; AGED; AMINES; ANTICONVULSANTS; AUTOIMMUNITY; BREAST NEOPLASMS; CLONAZEPAM; CYCLOHEXANECARBOXYLIC ACIDS; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAIT DISORDERS, NEUROLOGIC; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; MYOCLONUS; SEROTONIN UPTAKE INHIBITORS; TREMOR;

EID: 34548613943     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.9.1318     Document Type: Article

References (19)

1. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004;3(10):598-607.
2. Hallett M, Wilkins DE. Myoclonus in Alzheimer's disease and minipolymyoclonus. Adv Neurol. 1986;43:399-405.
3. Caviness JN, Adler CH, Beach TG, Wetjen KL, Caselli RJ. Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations. Mov Disord. 2002;17(4):657-662.
4. Hallett M. Myoclonus: relation to epilepsy. Epilepsia. 1985;26(suppl 1):S67-S77.
5. Wilkins DE, Hallett M, Erba G. Primary generalised epileptic myoclonus: a frequent manifestation of minipolymyoclonus of central origin. J Neurol Neurosurg Psychiatry. 1985;48(6):506-516.
6. Vernino S, Lennon VA. Neuronal ganglionic acetylcholine receptor autoimmunity. Ann N Y Acad Sci. 2003;998:211-214.
7. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49(2):146-154.
8. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62(7):1177-1182.
9. Garvey MJ, Tollefson GD. Occurrence of myoclonus in patients treated with cyclic antidepressants. Arch Gen Psychiatry. 1987;44(3):269-272.
10. Ghika-Schmid F, Ghika J, Vuadens P, Bogousslavsky J, Regli F, Despland PA. Acute reversible myoclonic encephalopathy associated with fluoxetine therapy. Mov Disord. 1997;12(4):622-623.
11. Potter JM, Reid DB, Shaw RJ, Hackett P, Hickman PE. Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. BMJ. 1989;299(6692):150-153.
12. Caviness JN, Evidente VG. Cortical myoclonus during lithium exposure. Arch Neurol. 2003;60(3):401-404.
13. Crespel A, Genton P, Berramdane M, et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 2005;65(5):762-764.
14. Sullivan JB Jr, Rumack BH, Peterson RG. Acute carbamazepine toxicity resulting from overdose. Neurology. 1981;31(5):621-624.
15. Alonso-Navarro H, Jimenez-Jimenez FJ. Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine. Clin Neuropharmacol. 2006;29(3):157-159.
16. Chan S, Turner MR, Young L, Gregory R. Cephalosporin-induced myoclonus. Neurology. 2006;66(6):E20.
17. Matsunaga K, Uozumi T, Qingrui L, Hashimoto T, Tsuji S. Amantadine-induced cortical myoclonus. Neurology. 2001;56(2):279-280.
18. Vadlamudi L, Wijdicks EF. Multifocal myoclonus due to verapamil overdose. Neurology. 2002;58(6):984.
19. Zhang C, Glenn DG, Bell WL, O'Donovan CA. Gabapentin-induced myoclonus in end-stage renal disease. Epilepsia. 2005;46(1):156-158.